Press Releases

Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2022

May 12, 2022

Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 25th Annual Meeting

May 2, 2022

Poseida Therapeutics to Present at BofA Securities 2022 Healthcare Conference

April 28, 2022

Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2021

March 10, 2022

Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

March 1, 2022

Poseida Therapeutics Hosts Second Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations

February 23, 2022

Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy

February 22, 2022

Poseida Therapeutics to Present Interim Results from Phase 1 Trial of P-PSMA-101 at ASCO Genitourinary Cancers Symposium

February 17, 2022

Poseida Therapeutics to Host Virtual R&D Day on February 23, 2022

February 9, 2022

Poseida Therapeutics Announces Eric Ostertag to Serve as Executive Chairman and Transition Role of CEO to Current President and CBO Mark Gergen

January 10, 2022